IJImen Jhaouat

Imen Jhaouat

*This is an algorithmically generated author record based on publicly available information.

Imen Jhaouat has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Anaïs Brassier

    Reference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité Paris France

    1 shared publication
  • Carmen Capito

    Department of Pediatric Surgery and Urology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) , Paris 75015

    1 shared publication
  • Claire Mayer

    Paediatric Hepatology Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Cité University , Paris 75015

    1 shared publication
  • Claire-Marine Bérat

    Reference Centre for Inherited Metabolic Disorders, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), INSERM-1151, INEM, G2M Network, MetabERN, Paris Cité University , Paris 75015

    1 shared publication
  • Cyrielle Aveline

    Department of Nuclear Medicine, Sorbonne Université, Tenon University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) , Paris 75020

    1 shared publication
  • Cécile Saint-Martin

    Department of Genetics, La Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) , Paris 75013

    1 shared publication

Latest Publications

  • Focal congenital hyperinsulinism: spontaneous glycemic improvement before surgery

    by Jean-Baptiste Arnoux, Claire Mayer, Imen Jhaouat, Cécile Saint-Martin, Claire-Marine Bérat, Lucile Altenburger, Anaïs Brassier, Juliette Bouchereau, Stefania Querciagrossa, Olivier Bustarret, et al.

    Context: Congenital hyperinsulinism (CHI) is the most common genetic cause of hypoglycemia in infants. Severe CHI may result from a focal pancreatic lesion (FoCHI), which can be surgically removed, although postoperative complications may occur, particularly after pancreatic head resections. Objective: To describe the spontaneous glycemic evolution of FoCHI before surgery and to assess the potential role of conservative management. Methods: We retrospectively reviewed medical records of patients with FoCHI managed at a single referral center. Congenital hyperinsulinism severity was classified according to the need for continuous gastric tube feeding (TF) to maintain glycemic control prior to surgery, defining a TF group and a no–tube feeding (NTF) group. Results: Thirty-nine patients were included: 12 (30.8%) in the NTF group and 27 (69.2%) in the TF group. Patients in the NTF group were diagnosed later (P = .022), had less severe initial hypoglycemia (P = .003), and 4/12 did not undergo surgery and were cured of hypoglycemia before 6 years of age. We developed an exploratory predictive score for early disease evolution, showing a specificity of 97%. Surgery was curative in most patients (96.3% in the TF group, 100% in the NTF group). Long-term complications were uncommon (8.6% vs 0%) and consisted exclusively of exocrine pancreatic insufficiency, occurring only after pancreatic head surgery (15.8%). Conclusion: Approximately 30% of infants with FoCHI demonstrated rapid early improvement. While surgery remains the standard curative treatment, a conservative approach may be considered in selected infants with pancreatic head lesions who show early favorable glycemic evolution, potentially after surgical exploration to assess postoperative risk.